GLP-1 drugs cut heart and kidney risks in type 1 diabetes study
A significant real-world evaluation suggests GLP-1 receptor agonists may supply coronary heart, kidney, and weight advantages in kind 1 diabetes ...
A significant real-world evaluation suggests GLP-1 receptor agonists may supply coronary heart, kidney, and weight advantages in kind 1 diabetes ...
Povetacicept, a Vertex Prescription drugs immunology drug designed to dam two targets, met the principle purpose of a Section 3 ...
Vertex mentioned Monday {that a} drug it secured as a part of a $4.9 billion acquisition efficiently diminished by half ...
The concept a excessive protein weight-reduction plan may harm kidney well being has been debated for years. From bodybuilding plans ...
Giant-scale UK Biobank information present that the EAT-Lancet planetary well being eating regimen is related to decrease CKD danger, with ...
Isabella Cueto covers the leading causes of death and disability: chronic diseases. Her focus includes autoimmune conditions and diseases of ...
After the largest ground water contamination in New Hampshire history, a state-commissioned study released this fall found significantly elevated rates ...
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective effects. In ...
MSC treatment had no effect on vascular cell apoptosis in the AVFs outflow veins. Credit: Science Translational Medicine (2025). DOI: ...
Strive Health, a value-based kidney care company, has raised $550 million in Series D funding, the company announced on Tuesday. ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.